Urgent

Nitrous oxide misuse — neuropsychiatric presentation

N2O misuse · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Recreational nitrous oxide ('nos', 'balloons') inactivates vitamin B12, causing a functional deficiency that produces subacute combined degeneration of the cord, peripheral neuropathy and neuropsychiatric symptoms (low mood, psychosis, cognitive impairment). It is now a controlled substance in the UK and increasingly seen in young people.

Red flags

  • Progressive ataxia, limb weakness or sensory loss (myelopathy)
  • Sphincter disturbance
  • Psychosis or marked cognitive impairment
  • Megaloblastic anaemia
  • Thromboembolism (hyperhomocysteinaemia risk)

Assessment

Differential diagnosis

  • Subacute combined degeneration of the cord (B12 functional deficiency)
  • Guillain-Barré syndrome or other neuropathy
  • Primary B12/folate deficiency
  • Multiple sclerosis or other demyelination
  • Functional neurological disorder; psychiatric illness

Investigations

  • Serum B12 (may be normal despite functional deficiency), active B12, homocysteine and methylmalonic acid (raised — more sensitive)
  • FBC and blood film (macrocytosis, hypersegmented neutrophils)
  • MRI spine (dorsal column signal change) if myelopathy suspected
  • Nerve conduction studies for neuropathy
  • Folate, U&E, LFTs; exclude other causes

Management

  • Take a focused substance-use history (quantity, frequency of N2O use)
  • Examine for peripheral neuropathy and myelopathy (sensory loss, ataxia, positive Romberg, brisk reflexes with upgoing plantars)
  • Send homocysteine/methylmalonic acid (more sensitive than serum B12)
  • Start high-dose B12 replacement promptly — do not wait for levels if clinical picture fits
  • Treat neuropsychiatric symptoms (psychosis/low mood) supportively
  • Advise cessation and refer to substance-misuse services
  • Refer to neurology for myelopathy/neuropathy
  • Arrange follow-up to monitor neurological recovery

Drugs & doses

Hydroxocobalamin — 1 mg IM on alternate days (e.g. for ~2 weeks) then maintenance; start early on clinical suspicion
Folic acid — 5 mg PO OD once B12 replacement started (avoid giving folate alone)
Lorazepam — 1-2 mg PO/IM for acute agitation/psychosis if needed; max 4 mg/24h
Analgesia (e.g. amitriptyline/gabapentin, specialist-led) for neuropathic pain

Disposition

Admit patients with myelopathy or significant neurological deficit for B12 replacement and neurology input; discharge milder cases with early B12, GP/neurology follow-up and substance-misuse referral, involving psychiatry for neuropsychiatric symptoms.

Complications & pitfalls

  • Irreversible spinal cord and nerve damage if untreated
  • Permanent gait and sensory impairment
  • Venous thromboembolism from hyperhomocysteinaemia
  • Psychiatric morbidity
  • Falls and functional disability

Exam pearls

  • Serum B12 can be normal — homocysteine and methylmalonic acid are more sensitive markers of functional deficiency
  • Start B12 replacement on clinical suspicion; do not await results — early treatment improves recovery
  • Give folate only after starting B12 to avoid worsening neurological deficit
  • Ask young people with neuropathy/myelopathy specifically about nitrous oxide use
  • N2O is now a Class C controlled substance in the UK — document and advise accordingly

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.